Kintara Therapeutics, Inc. (KTRA) Social Stream



Kintara Therapeutics, Inc. (KTRA): $7.54

0.51 (-6.31%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add KTRA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#231 of 385

in industry

Featured Post From StockTwits About KTRA

$KTRA New Press Release:

Kintara Therapeutics to Present at the Investor Summit Virtual Conference on August 17, 2021

Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company developing novel cancer therapies for patients who are failing or are resistant to current treatment regimens, announced today that its Chief Executive Officer, Saiid Zarrabian, will present at the Investor Summit Conference being held August 17 – 18, 2021. Mr. Zarrabian will deliver his corporate presentation on August 17, 2021 at 12:30 p.m.ET. Investors can also request a one-on-one meeting with Mr. Zarrabian to be arranged (...)

https://wchr.one/110920
WebChronicleToday, published August 12, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!